BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Rosiglitazone
,
rs2476601
,
BRCA1
,
T cell differentiation
,
Arthritis
,
Retina
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bladder cancer
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
ADH1B
ACTC1
SYNM
MYH11
C2orf40
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
PUJANA_CHEK2_PCC_NETWORK
FISCHER_DREAM_TARGETS
BENPORATH_CYCLING_GENES
heterocyclic compound binding
organic cyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
RNAi of EZH2 compared to microRNA-101 repressing EZH2 in cancer cells
RPE-1 hTERT and UM-UC-3 cells with RAS mutation treated with prexasertib & gemcitabine
Bladder cancer UM-UC-3 cells with NONO siRNA knockdown
Bladder cancer J82 cisplatin drug-resistant side and non-side population cells
Bladder cancer T24 cells with siRNA-mediated knockdown of RBM3
Explore Curated Studies Results
Literature
Most Relevant Literature
Bladder Cancer-Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasi…
Identification of potential phytochemical for the inhibition of non-muscle invasive bladder cancer (…
CTLA4 genetic variants associated with urothelial bladder cancer susceptibility.
25 years International Bladder Cancer Network (IBCN): The past, the present, and the future.
Risk factors for secondary bladder cancer following prostate cancer radiotherapy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
PENK Methylation Test for Detecting Bladder Cancer
Bladder Cancer Screening Trial
Autophagy Bladder Cancer
UroX Biomarker Bladder Cancer Study
Multi-parametric MRI in Patients of Bladder Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ